|
S
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
£
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
|
94-1622541
|
(State or other jurisdiction of
|
|
(I.R.S. Employer
|
incorporation or organization)
|
|
Identification No.)
|
Large accelerated filer
S
|
|
Accelerated filer
£
|
|
|
|
Non-accelerated filer
£
|
|
Smaller reporting company
£
|
(do not check if a smaller reporting company)
|
|
|
|
|
|
Page
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|
||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
Three Months Ended
|
|
||||||
|
December 31,
2011 |
|
January 1,
2011 |
|
||||
Net sales
|
$
|
190,767
|
|
|
$
|
183,111
|
|
|
Cost of sales
|
110,408
|
|
|
100,717
|
|
|
||
Gross profit
|
80,359
|
|
|
82,394
|
|
|
||
Operating expenses:
|
|
|
|
|
|
|
||
Research and development
|
18,779
|
|
|
18,530
|
|
|
||
Selling, general and administrative
|
34,631
|
|
|
36,078
|
|
|
||
Amortization of intangible assets
|
1,636
|
|
|
2,095
|
|
|
||
Total operating expenses
|
55,046
|
|
|
56,703
|
|
|
||
Income from operations
|
25,313
|
|
|
25,691
|
|
|
||
Other income (expense):
|
|
|
|
|
|
|||
Interest and dividend income
|
202
|
|
|
183
|
|
|
||
Interest expense
|
(2
|
)
|
|
(15
|
)
|
|
||
Other—net
|
318
|
|
|
1,586
|
|
|
||
Total other income (expense), net
|
518
|
|
|
1,754
|
|
|
||
Income before income taxes
|
25,831
|
|
|
27,445
|
|
|
||
Provision for income taxes
|
8,780
|
|
|
8,332
|
|
|
||
Net income
|
$
|
17,051
|
|
|
$
|
19,113
|
|
|
|
|
|
|
|
||||
Net income per share:
|
|
|
|
|
|
|
||
Basic
|
$
|
0.73
|
|
|
$
|
0.77
|
|
|
Diluted
|
$
|
0.71
|
|
|
$
|
0.76
|
|
|
|
|
|
|
|
||||
Shares used in computation:
|
|
|
|
|
|
|
||
Basic
|
23,462
|
|
|
24,688
|
|
|
||
Diluted
|
23,961
|
|
|
25,268
|
|
|
|
December 31,
2011 |
|
October 1,
2011 |
||||
ASSETS
|
|
|
|
|
|
||
Current assets:
|
|
|
|
|
|
||
Cash and cash equivalents
|
$
|
167,662
|
|
|
$
|
167,061
|
|
Short-term investments
|
35,421
|
|
|
53,142
|
|
||
Accounts receivable—net of allowances of $1,546 and $1,439, respectively
|
130,581
|
|
|
141,037
|
|
||
Inventories
|
148,047
|
|
|
152,385
|
|
||
Prepaid expenses and other assets
|
52,314
|
|
|
44,964
|
|
||
Deferred tax assets
|
23,265
|
|
|
22,057
|
|
||
Total current assets
|
557,290
|
|
|
580,646
|
|
||
Property and equipment, net
|
106,028
|
|
|
104,504
|
|
||
Goodwill
|
74,756
|
|
|
75,954
|
|
||
Intangible assets, net
|
16,405
|
|
|
17,980
|
|
||
Other assets
|
63,650
|
|
|
64,182
|
|
||
Total assets
|
$
|
818,129
|
|
|
$
|
843,266
|
|
|
|
|
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
||
Current liabilities:
|
|
|
|
|
|
||
Current portion of long-term obligations
|
$
|
15
|
|
|
$
|
15
|
|
Accounts payable
|
35,379
|
|
|
39,841
|
|
||
Income taxes payable
|
15,258
|
|
|
23,929
|
|
||
Other current liabilities
|
94,573
|
|
|
98,620
|
|
||
Total current liabilities
|
145,225
|
|
|
162,405
|
|
||
Long-term obligations
|
15
|
|
|
19
|
|
||
Other long-term liabilities
|
63,565
|
|
|
62,841
|
|
||
Commitments and contingencies (Note 11)
|
|
|
|
|
|
||
Stockholders’ equity:
|
|
|
|
|
|
||
Common stock, par value $.01 per share:
|
|
|
|
|
|
||
Authorized—500,000 shares
|
|
|
|
|
|
||
Outstanding—23,531 shares and 23,722 shares, respectively
|
234
|
|
|
236
|
|
||
Additional paid-in capital
|
114,829
|
|
|
130,250
|
|
||
Accumulated other comprehensive income
|
40,916
|
|
|
51,221
|
|
||
Retained earnings
|
453,345
|
|
|
436,294
|
|
||
Total stockholders’ equity
|
609,324
|
|
|
618,001
|
|
||
Total liabilities and stockholders’ equity
|
$
|
818,129
|
|
|
$
|
843,266
|
|
|
Three Months Ended
|
||||||
|
December 31,
2011 |
|
January 1,
2011 |
||||
Cash flows from operating activities:
|
|
|
|
|
|
||
Net income
|
$
|
17,051
|
|
|
$
|
19,113
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|||
Depreciation and amortization
|
5,828
|
|
|
4,767
|
|
||
Amortization of intangible assets
|
1,636
|
|
|
2,095
|
|
||
Deferred income taxes
|
(527
|
)
|
|
8,096
|
|
||
Tax benefit from employee stock options
|
955
|
|
|
1,543
|
|
||
Loss on disposal of property and equipment
|
42
|
|
|
156
|
|
||
Stock-based compensation
|
4,022
|
|
|
2,922
|
|
||
Excess tax benefit from stock-based compensation arrangements
|
(1,681
|
)
|
|
(1,678
|
)
|
||
Other non-cash (income) expense
|
154
|
|
|
(58
|
)
|
||
Changes in assets and liabilities, net of effect of acquisitions:
|
|
|
|
|
|
||
Accounts receivable
|
9,161
|
|
|
1,522
|
|
||
Inventories
|
2,671
|
|
|
(9,109
|
)
|
||
Prepaid expenses and other assets
|
(7,321
|
)
|
|
(2,443
|
)
|
||
Other assets
|
(497
|
)
|
|
(2,011
|
)
|
||
Accounts payable
|
(4,715
|
)
|
|
2,687
|
|
||
Income taxes payable/receivable
|
(8,210
|
)
|
|
(1,314
|
)
|
||
Other current liabilities
|
(3,110
|
)
|
|
1,250
|
|
||
Other long-term liabilities
|
676
|
|
|
2,431
|
|
||
Net cash provided by operating activities
|
16,135
|
|
|
29,969
|
|
||
|
|
|
|
||||
Cash flows from investing activities:
|
|
|
|
|
|
||
Purchases of property and equipment
|
(8,139
|
)
|
|
(5,129
|
)
|
||
Proceeds from dispositions of property and equipment
|
26
|
|
|
—
|
|
||
Purchases of available-for-sale securities
|
(12,593
|
)
|
|
(71,093
|
)
|
||
Proceeds from sales and maturities of available-for-sale securities
|
30,188
|
|
|
19,506
|
|
||
Changes in restricted cash
|
—
|
|
|
(68
|
)
|
||
Net cash provided by (used in) investing activities
|
9,482
|
|
|
(56,784
|
)
|
||
|
|
|
|
||||
Cash flows from financing activities:
|
|
|
|
|
|
||
Short-term borrowings
|
4,786
|
|
|
285
|
|
||
Repayments of short-term borrowing
|
(4,786
|
)
|
|
(285
|
)
|
||
Net change in capital lease obligations
|
(4
|
)
|
|
(5
|
)
|
||
Issuance of common stock under employee stock option and purchase plans
|
4,568
|
|
|
17,331
|
|
||
Repurchase of common stock
|
(20,665
|
)
|
|
—
|
|
||
Net settlement of restricted common stock
|
(4,413
|
)
|
|
(2,086
|
)
|
||
Excess tax benefits from stock-based compensation arrangements
|
1,681
|
|
|
1,678
|
|
||
Net cash provided by (used in) financing activities
|
(18,833
|
)
|
|
16,918
|
|
||
Effect of exchange rate changes on cash and cash equivalents
|
(6,183
|
)
|
|
(7,968
|
)
|
||
Net increase (decrease) in cash and cash equivalents
|
601
|
|
|
(17,865
|
)
|
||
Cash and cash equivalents, beginning of period
|
167,061
|
|
|
245,380
|
|
||
Cash and cash equivalents, end of period
|
$
|
167,662
|
|
|
$
|
227,515
|
|
Supplemental disclosure of cash flow information:
|
|
|
|
|
|
||
Cash paid during the period for:
|
|
|
|
|
|
||
Interest
|
$
|
3
|
|
|
$
|
11
|
|
Income taxes
|
$
|
25,818
|
|
|
$
|
3,973
|
|
Cash received during the period for:
|
|
|
|
|
|
||
Income taxes
|
$
|
9,662
|
|
|
$
|
3,908
|
|
|
|
|
|
||||
Non-cash investing and financing activities:
|
|
|
|
|
|
||
Unpaid property and equipment
|
$
|
1,933
|
|
|
$
|
889
|
|
Tangible assets
|
$
|
4,617
|
|
Goodwill
|
5,807
|
|
|
Intangible assets:
|
|
|
|
Existing technology
|
3,120
|
|
|
In-process R&D
|
570
|
|
|
Customer lists
|
1,880
|
|
|
Trade name
|
410
|
|
|
Non-compete agreements
|
60
|
|
|
Liabilities assumed
|
(1,965)
|
|
|
Total
|
$
|
14,499
|
|
|
Quoted Prices in
Active Markets
for Identical
Assets
|
|
Significant
Other
Observable
Inputs
|
|
Total Fair
Value
|
||||||
|
(Level 1)
|
|
(Level 2)
|
|
|
||||||
Money market fund deposits (1)
|
$
|
16,728
|
|
|
$
|
—
|
|
|
$
|
16,728
|
|
Certificates of deposit (2)
|
—
|
|
|
66,916
|
|
|
66,916
|
|
|||
U.S. and international government obligations (3)
|
—
|
|
|
57,642
|
|
|
57,642
|
|
|||
Corporate notes and obligations (4)
|
—
|
|
|
31,259
|
|
|
31,259
|
|
|||
Foreign currency contracts (5)
|
—
|
|
|
627
|
|
|
627
|
|
|||
Mutual funds — Deferred comp and supplemental plan (6)
|
8,348
|
|
|
—
|
|
|
8,348
|
|
|
Quoted Prices in
Active Markets
for Identical
Assets
|
|
Significant
Other
Observable
Inputs
|
|
Total Fair
Value
|
||||||
|
(Level 1)
|
|
(Level 2)
|
|
|
||||||
Money market fund deposits(1)
|
$
|
8,135
|
|
|
$
|
—
|
|
|
$
|
8,135
|
|
Certificates of deposit(2)
|
—
|
|
|
65,941
|
|
|
65,941
|
|
|||
U.S. and international government obligations(3)
|
—
|
|
|
62,079
|
|
|
62,079
|
|
|||
Corporate notes and obligations(4)
|
—
|
|
|
48,967
|
|
|
48,967
|
|
|||
Foreign currency contracts(5)
|
—
|
|
|
181
|
|
|
181
|
|
|||
Mutual funds—Deferred comp and supplemental plan(6)
|
7,830
|
|
|
—
|
|
|
7,830
|
|
(1)
|
Included in cash and cash equivalents on the Condensed Consolidated Balance Sheet.
|
(2)
|
Includes
$59,431
recorded in cash and cash equivalents and
$6,510
recorded in short-term investments on the Condensed Consolidated Balance Sheet.
|
(3)
|
Includes
$60,978
recorded in cash and cash equivalents and
$1,101
recorded in short-term investments on the Condensed Consolidated Balance Sheet.
|
(4)
|
Includes
$3,436
recorded in cash and cash equivalents and
$45,531
recorded in short-term investments on the Condensed Consolidated Balance Sheet.
|
(5)
|
Includes
$578
recorded in prepaid expenses and other assets and
$397
recorded in other current liabilities on the Condensed Consolidated Balance Sheet.
|
(6)
|
Includes
$2,844
recorded in prepaid expenses and other assets and
$4,986
recorded in other assets on the Condensed Consolidated Balance Sheet.
|
|
U.S. Notional Contract Value
|
|
U.S. Notional Fair Value
|
||||||||||||
|
December 31, 2011
|
|
October 1, 2011
|
|
December 31, 2011
|
|
October 1, 2011
|
||||||||
Euro currency hedge contracts
|
|
|
|
|
|
|
|
|
|
|
|
||||
Purchase
|
$
|
47,843
|
|
|
$
|
42,488
|
|
|
$
|
47,344
|
|
|
$
|
42,103
|
|
Sell
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Net
|
$
|
47,843
|
|
|
$
|
42,488
|
|
|
$
|
47,344
|
|
|
$
|
42,103
|
|
Other foreign currency hedge contracts
|
|
|
|
|
|
|
|
|
|
|
|
||||
Purchase
|
$
|
—
|
|
|
$
|
2,351
|
|
|
$
|
—
|
|
|
$
|
2,355
|
|
Sell
|
(47,535
|
)
|
|
(16,783
|
)
|
|
(47,663
|
)
|
|
(16,221
|
)
|
||||
Net
|
$
|
(47,535
|
)
|
|
$
|
(14,432
|
)
|
|
$
|
(47,663
|
)
|
|
$
|
(13,866
|
)
|
|
|
Amount of Gain or (Loss) Recognized in
|
|||
|
|
Income on Derivatives
|
|||
|
|
Three Months Ended
|
|
||
|
|
December 31, 2011
|
|
||
Derivatives not designated as hedging instruments
|
|
|
|
||
Foreign exchange contracts
|
|
$
|
1,982
|
|
|
|
|
Amount of Gain or (Loss) Recognized in
|
|||
|
|
Income on Derivatives
|
|||
|
|
Three Months Ended
|
|
||
|
|
January 1, 2011
|
|
||
Derivatives not designated as hedging instruments
|
|
|
|
||
Foreign exchange contracts
|
|
$
|
1,104
|
|
|
|
December 31, 2011
|
||||||||||||||
|
Cost Basis
|
|
Unrealized
Gains
|
|
Unrealized
Losses
|
|
Fair Value
|
||||||||
Cash and cash equivalents
|
$
|
167,655
|
|
|
$
|
7
|
|
|
$
|
—
|
|
|
$
|
167,662
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Short-term investments:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Available-for-sale securities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Certificates of deposit
|
$
|
2,000
|
|
|
$
|
2
|
|
|
$
|
—
|
|
|
$
|
2,002
|
|
International government obligations
|
2,667
|
|
|
61
|
|
|
(5
|
)
|
|
2,723
|
|
||||
Corporate notes and obligations
|
30,482
|
|
|
215
|
|
|
(1
|
)
|
|
30,696
|
|
||||
Total short-term investments
|
$
|
35,149
|
|
|
$
|
278
|
|
|
$
|
(6
|
)
|
|
$
|
35,421
|
|
|
October 1, 2011
|
||||||||||||||
|
Cost Basis
|
|
Unrealized
Gains
|
|
Unrealized
Losses
|
|
Fair Value
|
||||||||
Cash and cash equivalents
|
$
|
166,931
|
|
|
$
|
131
|
|
|
$
|
(1
|
)
|
|
$
|
167,061
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Short-term investments:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Available-for-sale securities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Certificates of deposit
|
$
|
6,500
|
|
|
$
|
10
|
|
|
$
|
—
|
|
|
$
|
6,510
|
|
International government obligations
|
1,101
|
|
|
1
|
|
|
(1
|
)
|
|
1,101
|
|
||||
Corporate notes and obligations
|
45,282
|
|
|
275
|
|
|
(26
|
)
|
|
45,531
|
|
||||
Total short-term investments
|
$
|
52,883
|
|
|
$
|
286
|
|
|
$
|
(27
|
)
|
|
$
|
53,142
|
|
|
December 31, 2011
|
|
October 1, 2011
|
||||||||||||
|
Amortized Cost
|
|
Estimated Fair Value
|
|
Amortized Cost
|
|
Estimated Fair Value
|
||||||||
Due in less than 1 year
|
$
|
33,149
|
|
|
$
|
33,419
|
|
|
$
|
46,383
|
|
|
$
|
46,632
|
|
Total investments in available-for-sale debt securities
|
$
|
33,149
|
|
|
$
|
33,419
|
|
|
$
|
46,383
|
|
|
$
|
46,632
|
|
|
Commercial
Lasers and
Components
|
|
Specialty
Lasers and
Systems
|
|
Total
|
||||||
Balance as of October 1, 2011
|
$
|
6,365
|
|
|
$
|
69,589
|
|
|
$
|
75,954
|
|
Translation adjustments and other
|
(2
|
)
|
|
(1,196
|
)
|
|
(1,198
|
)
|
|||
Balance as of December 31, 2011
|
$
|
6,363
|
|
|
$
|
68,393
|
|
|
$
|
74,756
|
|
|
December 31, 2011
|
|
October 1, 2011
|
||||||||||||||||||||
|
Gross
Carrying
Amount
|
|
Accumulated
Amortization
|
|
Net
|
|
Gross
Carrying
Amount
|
|
Accumulated
Amortization
|
|
Net
|
||||||||||||
Existing technology
|
$
|
52,011
|
|
|
$
|
(42,646
|
)
|
|
$
|
9,365
|
|
|
$
|
52,283
|
|
|
$
|
(41,615
|
)
|
|
$
|
10,668
|
|
Patents
|
6,982
|
|
|
(6,956
|
)
|
|
26
|
|
|
7,246
|
|
|
(7,220
|
)
|
|
26
|
|
||||||
Customer lists
|
9,748
|
|
|
(5,248
|
)
|
|
4,500
|
|
|
9,807
|
|
|
(5,142
|
)
|
|
4,665
|
|
||||||
Trade name
|
3,483
|
|
|
(2,539
|
)
|
|
944
|
|
|
3,566
|
|
|
(2,504
|
)
|
|
1,062
|
|
||||||
Non-compete agreement
|
831
|
|
|
(764
|
)
|
|
67
|
|
|
837
|
|
|
(784
|
)
|
|
53
|
|
||||||
Production know-how
|
910
|
|
|
(627
|
)
|
|
283
|
|
|
910
|
|
|
(621
|
)
|
|
289
|
|
||||||
In-process research & development
|
1,220
|
|
|
—
|
|
|
1,220
|
|
|
1,217
|
|
|
—
|
|
|
1,217
|
|
||||||
Total
|
$
|
75,185
|
|
|
$
|
(58,780
|
)
|
|
$
|
16,405
|
|
|
$
|
75,866
|
|
|
$
|
(57,886
|
)
|
|
$
|
17,980
|
|
|
Estimated
Amortization
Expense
|
||
2012 (remainder)
|
$
|
4,710
|
|
2013
|
4,857
|
|
|
2014
|
3,373
|
|
|
2015
|
2,044
|
|
|
2016
|
1,257
|
|
|
2017
|
154
|
|
|
Thereafter
|
10
|
|
|
Total
|
$
|
16,405
|
|
|
December 31,
2011 |
|
October 1,
2011 |
||||
Purchased parts and assemblies
|
$
|
41,844
|
|
|
$
|
44,824
|
|
Work-in-process
|
54,582
|
|
|
52,457
|
|
||
Finished goods
|
51,621
|
|
|
55,104
|
|
||
Total inventories
|
$
|
148,047
|
|
|
$
|
152,385
|
|
|
December 31,
2011 |
|
October 1,
2011 |
||||
Prepaid and refundable income taxes
|
$
|
9,517
|
|
|
$
|
9,193
|
|
Prepaid expenses and other
|
42,797
|
|
|
35,771
|
|
||
Total prepaid expenses and other assets
|
$
|
52,314
|
|
|
$
|
44,964
|
|
|
December 31,
2011 |
|
October 1,
2011 |
||||
Assets related to deferred compensation arrangements
|
$
|
23,133
|
|
|
$
|
22,737
|
|
Deferred tax assets
|
36,136
|
|
|
37,156
|
|
||
Other assets
|
4,381
|
|
|
4,289
|
|
||
Total other assets
|
$
|
63,650
|
|
|
$
|
64,182
|
|
|
December 31,
2011 |
|
October 1,
2011 |
||||
Accrued payroll and benefits
|
$
|
26,703
|
|
|
$
|
39,639
|
|
Deferred income
|
15,318
|
|
|
14,893
|
|
||
Reserve for warranty
|
16,035
|
|
|
16,704
|
|
||
Accrued expenses and other
|
13,590
|
|
|
12,473
|
|
||
Other taxes payable
|
18,343
|
|
|
11,067
|
|
||
Accrued restructuring charges
|
615
|
|
|
634
|
|
||
Customer deposits
|
3,969
|
|
|
3,210
|
|
||
Total other current liabilities
|
$
|
94,573
|
|
|
$
|
98,620
|
|
|
Severance
Related
|
|
Facilities-
related
Charges
|
|
Other
Restructuring
Costs
|
|
Total
|
||||||||
Balance at October 2, 2010
|
$
|
912
|
|
|
$
|
17
|
|
|
$
|
1,303
|
|
|
$
|
2,232
|
|
Provisions
|
218
|
|
|
—
|
|
|
87
|
|
|
305
|
|
||||
Payments and other
|
(228
|
)
|
|
(17
|
)
|
|
(491
|
)
|
|
(736
|
)
|
||||
Balance at January 1, 2011
|
$
|
902
|
|
|
$
|
—
|
|
|
$
|
899
|
|
|
$
|
1,801
|
|
|
|
|
|
|
|
|
|
||||||||
Balance at October 1, 2011
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
634
|
|
|
$
|
634
|
|
Payments and other
|
—
|
|
|
—
|
|
|
(19
|
)
|
|
(19
|
)
|
||||
Balance at December 31, 2011
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
615
|
|
|
$
|
615
|
|
|
Three Months Ended
|
||||||
|
December 31,
2011 |
|
January 1,
2011 |
||||
Beginning balance
|
$
|
16,704
|
|
|
$
|
13,499
|
|
Additions related to current period sales
|
6,374
|
|
|
5,876
|
|
||
Warranty costs incurred in the current period
|
(7,249
|
)
|
|
(5,297
|
)
|
||
Adjustments to accruals, including foreign exchange
|
206
|
|
|
(178
|
)
|
||
Ending balance
|
$
|
16,035
|
|
|
$
|
13,900
|
|
|
December 31,
2011 |
|
October 1,
2011 |
||||
Long-term taxes payable
|
$
|
28,195
|
|
|
$
|
27,775
|
|
Deferred compensation
|
23,274
|
|
|
22,685
|
|
||
Deferred tax liabilities
|
1,953
|
|
|
2,194
|
|
||
Deferred income
|
2,483
|
|
|
2,636
|
|
||
Asset retirement obligations
|
1,888
|
|
|
1,878
|
|
||
Other long-term liabilities
|
5,772
|
|
|
5,673
|
|
||
Total other long-term liabilities
|
$
|
63,565
|
|
|
$
|
62,841
|
|
|
|
Employee Stock Purchase Plan
|
|||||||
|
|
Three Months Ended
|
|
||||||
|
|
December 31,
2011 |
|
January 1,
2011 |
|
||||
Expected life in years
|
|
0.5
|
|
|
0.5
|
|
|
||
Expected volatility
|
|
49.3
|
%
|
|
30.6
|
%
|
|
||
Risk-free interest rate
|
|
0.1
|
%
|
|
0.2
|
%
|
|
||
Expected dividends
|
|
—
|
|
|
—
|
|
|
||
Weighted average fair value per share
|
|
$
|
14.93
|
|
|
$
|
9.78
|
|
|
(1)
|
There were
no
options granted during the
three months ended
December 31, 2011
and
January 1, 2011
.
|
•
|
The service based restricted stock awards generally vest
three
years from the date of grant.
|
•
|
The service based restricted stock unit awards are generally subject to annual vesting over
three
years from the date of grant.
|
•
|
The market-based performance restricted stock unit award grants are generally either subject to annual vesting over
three
years from the date of grant or
subject to a single vest measurement
three
years from the date of grant, depending upon achievement of performance measurements ("Performance RSUs") based on the performance of the Company's Total Shareholder Returns (as defined) compared with the performance of the Russell 2000 Index.
|
Risk-free interest rate
|
0.39
|
%
|
Volatility
|
41.8
|
%
|
|
Three Months Ended
|
|
||||||
|
December 31, 2011
|
|
January 1, 2011
|
|
||||
Cost of sales
|
$
|
369
|
|
|
$
|
244
|
|
|
Research and development
|
393
|
|
|
337
|
|
|
||
Selling, general and administrative
|
3,260
|
|
|
2,342
|
|
|
||
Income tax benefit
|
(1,328
|
)
|
|
(675
|
)
|
|
||
|
$
|
2,694
|
|
|
$
|
2,248
|
|
|
|
Number of
Shares
|
|
Weighted
Average
Exercise Price
Per Share
|
|
Weighted
Average
Remaining
Contractual
Term in Years
|
|
Aggregate
Intrinsic Value
|
||||||
Outstanding at October 1, 2011
|
917
|
|
|
$
|
27.80
|
|
|
|
|
|
|
|
|
Granted
|
—
|
|
|
—
|
|
|
|
|
|
|
|
||
Exercised
|
(66
|
)
|
|
26.27
|
|
|
|
|
|
|
|
||
Forfeitures
|
—
|
|
|
—
|
|
|
|
|
|
|
|
||
Expirations
|
—
|
|
|
—
|
|
|
|
|
|
|
|
||
Outstanding at December 31, 2011
|
851
|
|
|
$
|
27.91
|
|
|
4.0
|
|
|
$
|
20,742
|
|
Vested and expected to vest at December 31, 2011
|
845
|
|
|
$
|
27.87
|
|
|
4.0
|
|
|
$
|
20,626
|
|
Exercisable at December 31, 2011
|
662
|
|
|
$
|
27.67
|
|
|
3.5
|
|
|
$
|
16,291
|
|
|
Time Based Restricted Stock Units
|
|
Market-Based Performance Restricted Stock Units
|
||||||||||
|
Number of
Shares(1)
|
|
Weighted
Average
Grant Date
Fair Value
|
|
Number of
Shares(2)
|
|
Weighted
Average Grant Date Fair Value |
||||||
Nonvested stock at October 1, 2011
|
404
|
|
|
$
|
34.71
|
|
|
101
|
|
|
$
|
49.77
|
|
Granted
|
224
|
|
|
53.46
|
|
|
95
|
|
|
63.85
|
|
||
Vested
|
(172
|
)
|
|
30.93
|
|
|
(44
|
)
|
|
53.18
|
|
||
Forfeited
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||
Nonvested stock at December 31, 2011
|
456
|
|
|
$
|
45.37
|
|
|
152
|
|
|
$
|
57.55
|
|
|
Three Months Ended
|
|
||||||
|
December 31,
2011 |
|
January 1,
2011 |
|
||||
|
|
|
|
|
||||
Net income
|
$
|
17,051
|
|
|
$
|
19,113
|
|
|
Other comprehensive income (loss):
|
|
|
|
|
||||
Translation adjustment
|
(10,321
|
)
|
|
(11,426
|
)
|
|
||
Changes in unrealized gains on available-for-sale securities, net of taxes
|
16
|
|
|
(1
|
)
|
|
||
Other comprehensive income (loss), net of tax
|
(10,305
|
)
|
|
(11,427
|
)
|
|
||
Comprehensive income (loss)
|
$
|
6,746
|
|
|
$
|
7,686
|
|
|
|
Three Months Ended
|
|
||||||
|
December 31,
2011 |
|
January 1,
2011 |
|
||||
Weighted average shares outstanding —basic
|
23,462
|
|
|
24,688
|
|
|
||
Dilutive effect of employee stock awards
|
499
|
|
|
580
|
|
|
||
Weighted average shares outstanding—diluted
|
23,961
|
|
|
25,268
|
|
|
||
|
|
|
|
|
||||
Net income
|
$
|
17,051
|
|
|
$
|
19,113
|
|
|
|
|
|
|
|
||||
Net income per basic share
|
$
|
0.73
|
|
|
$
|
0.77
|
|
|
Net income per diluted share
|
$
|
0.71
|
|
|
$
|
0.76
|
|
|
|
Three Months Ended
|
|
||||||
|
December 31,
2011 |
|
January 1,
2011 |
|
||||
Foreign exchange gain
|
$
|
313
|
|
|
$
|
6
|
|
|
Gain (loss) on deferred compensation investments, net
|
(41
|
)
|
|
1,554
|
|
|
||
Interest and dividend income
|
202
|
|
|
183
|
|
|
||
Interest expense
|
(2
|
)
|
|
(15
|
)
|
|
||
Other—net
|
46
|
|
|
26
|
|
|
||
Other income (expense), net
|
$
|
518
|
|
|
$
|
1,754
|
|
|
|
Three Months Ended
|
|
||||||
|
December 31,
2011 |
|
January 1,
2011 |
|
||||
Net sales:
|
|
|
|
|
||||
Commercial Lasers and Components
|
$
|
55,150
|
|
|
$
|
61,358
|
|
|
Specialty Laser Systems
|
135,617
|
|
|
121,753
|
|
|
||
Corporate and other
|
—
|
|
|
—
|
|
|
||
Total net sales
|
$
|
190,767
|
|
|
$
|
183,111
|
|
|
|
|
|
|
|
||||
Income (loss) from operations:
|
|
|
|
|
||||
Commercial Lasers and Components
|
$
|
4,020
|
|
|
$
|
8,325
|
|
|
Specialty Laser Systems
|
31,030
|
|
|
28,861
|
|
|
||
Corporate and other
|
(9,737
|
)
|
|
(11,495
|
)
|
|
||
Total income from operations
|
$
|
25,313
|
|
|
$
|
25,691
|
|
|
•
|
Leverage our technology portfolio and application engineering to lead the proliferation of photonics into
|
•
|
Optimize our leadership position in existing markets
—There are a number of markets where we have historically been at the forefront of technological development and product deployment and from which we have derived a substantial portion of our revenues. We plan to optimize our financial returns from these markets.
|
•
|
Maintain and develop additional strong collaborative customer and industry relationships
—We believe that the Coherent brand name and reputation for product quality, technical performance and customer satisfaction will help us to further develop our loyal customer base. We plan to maintain our current customer relationships and develop new ones with customers who are industry leaders and work together with these customers to design and develop innovative product systems and solutions as they develop new technologies.
|
•
|
Develop and acquire new technologies and market share
—We will continue to enhance our market position through our existing technologies and develop new technologies through our internal research and development efforts, as well as through the acquisition of additional complementary technologies, intellectual property, manufacturing processes and product offerings.
|
•
|
Streamline our manufacturing structure and improve our cost structure
—We will focus on optimizing the mix of products that we manufacture internally and externally. We will utilize vertical integration where our internal manufacturing process is considered proprietary and seek to leverage external sources when the capabilities and cost structure are well developed and on a path towards commoditization.
|
•
|
Focus on long-term improvement of adjusted EBITDA, in dollars and as a percentage of net sales
—We define adjusted EBITDA as operating income adjusted for depreciation, amortization, stock compensation expenses, major restructuring costs and certain other non-operating income and expense items. Key initiatives to reach our goals for EBITDA improvements include utilization of our Asian manufacturing locations, rationalizing our supply chain and continued leveraging of our infrastructure.
|
|
Three Months Ended
|
|
|
|
|
|||||||||
|
December 31, 2011
|
|
January 1, 2011
|
|
Change
|
|
% Change
|
|||||||
|
(Dollars in thousands)
|
|||||||||||||
|
|
|
|
|
|
|
|
|||||||
Bookings
|
$
|
201,848
|
|
|
$
|
234,424
|
|
|
$
|
(32,576
|
)
|
|
(13.9
|
)%
|
Book-to-bill ratio
|
1.06
|
|
|
1.28
|
|
|
(0.22
|
)
|
|
(17.2
|
)%
|
|||
Net sales—Commercial Lasers and Components
|
$
|
55,150
|
|
|
$
|
61,358
|
|
|
$
|
(6,208
|
)
|
|
(10.1
|
)%
|
Net sales—Specialty Lasers and Systems
|
$
|
135,617
|
|
|
$
|
121,753
|
|
|
$
|
13,864
|
|
|
11.4
|
%
|
Gross profit as a percentage of net sales—Commercial Lasers and Components
|
39.0
|
%
|
|
43.7
|
%
|
|
(4.7
|
)%
|
|
(10.8
|
)%
|
|||
Gross profit as a percentage of net sales—
Specialty Lasers and Systems
|
43.8
|
%
|
|
46.0
|
%
|
|
(2.2
|
)%
|
|
(4.8
|
)%
|
|||
Research and development as a percentage of net sales
|
9.8
|
%
|
|
10.1
|
%
|
|
(0.3
|
)%
|
|
(3.0
|
)%
|
|||
Income before income taxes
|
$
|
25,831
|
|
|
$
|
27,445
|
|
|
$
|
(1,614
|
)
|
|
(5.9
|
)%
|
Net cash provided by operating activities
|
$
|
16,135
|
|
|
$
|
29,969
|
|
|
$
|
(13,834
|
)
|
|
(46.2
|
)%
|
Days sales outstanding in receivables
|
61.6
|
|
|
53.1
|
|
|
8.5
|
|
|
16.0
|
%
|
|||
First quarter inventory turns
|
3.0
|
|
|
3.3
|
|
|
(0.3
|
)
|
|
(9.1
|
)%
|
|||
Capital spending as a percentage of net sales
|
4.3
|
%
|
|
2.8
|
%
|
|
1.5
|
%
|
|
53.6
|
%
|
|
Three Months Ended
|
|
||||
|
December 31,
2011 |
|
January 1,
2011 |
|
||
Net sales
|
100.0
|
%
|
|
100.0
|
%
|
|
Cost of sales
|
57.9
|
%
|
|
55.0
|
%
|
|
Gross profit
|
42.1
|
%
|
|
45.0
|
%
|
|
Operating expenses:
|
|
|
|
|
||
Research and development
|
9.8
|
%
|
|
10.1
|
%
|
|
Selling, general and administrative
|
18.2
|
%
|
|
19.7
|
%
|
|
Amortization of intangible assets
|
0.9
|
%
|
|
1.2
|
%
|
|
Total operating expenses
|
28.9
|
%
|
|
31.0
|
%
|
|
Income from operations
|
13.2
|
%
|
|
14.0
|
%
|
|
Other income (net)
|
0.3
|
%
|
|
1.0
|
%
|
|
Income before income taxes
|
13.5
|
%
|
|
15.0
|
%
|
|
Provision for income taxes
|
4.6
|
%
|
|
4.6
|
%
|
|
Net income
|
8.9
|
%
|
|
10.4
|
%
|
|
|
Three Months Ended
|
||||||||||||
|
December 31, 2011
|
|
January 1, 2011
|
||||||||||
|
Amount
|
|
Percentage
of total
net sales
|
|
Amount
|
|
Percentage
of total
net sales
|
||||||
Consolidated:
|
|
|
|
|
|
|
|
||||||
Microelectronics
|
$
|
92,892
|
|
|
48.7
|
%
|
|
$
|
84,431
|
|
|
46.1
|
%
|
OEM components and instrumentation
|
35,940
|
|
|
18.8
|
%
|
|
38,350
|
|
|
20.9
|
%
|
||
Materials processing
|
23,379
|
|
|
12.3
|
%
|
|
22,275
|
|
|
12.2
|
%
|
||
Scientific and government programs
|
38,556
|
|
|
20.2
|
%
|
|
38,055
|
|
|
20.8
|
%
|
||
Total
|
$
|
190,767
|
|
|
100.0
|
%
|
|
$
|
183,111
|
|
|
100.0
|
%
|
|
Three Months Ended
|
||||||||||||
|
December 31, 2011
|
|
January 1, 2011
|
||||||||||
|
Amount
|
|
Percentage
of total
net sales
|
|
Amount
|
|
Percentage
of total
net sales
|
||||||
Consolidated:
|
|
|
|
|
|
|
|
||||||
Commercial Lasers and Components (CLC)
|
$
|
55,150
|
|
|
28.9
|
%
|
|
$
|
61,358
|
|
|
33.5
|
%
|
Specialty Lasers and Systems (SLS)
|
135,617
|
|
|
71.1
|
%
|
|
121,753
|
|
|
66.5
|
%
|
||
Total
|
$
|
190,767
|
|
|
100.0
|
%
|
|
$
|
183,111
|
|
|
100.0
|
%
|
|
Three Months Ended
|
||||||||||||
|
December 31, 2011
|
|
January 1, 2011
|
||||||||||
|
Amount
|
|
Percentage of
total net sales
|
|
Amount
|
|
Percentage of
total net sales
|
||||||
|
(Dollars in thousands)
|
||||||||||||
Research and development
|
$
|
18,779
|
|
|
9.8
|
%
|
|
$
|
18,530
|
|
|
10.1
|
%
|
Selling, general and administrative
|
34,631
|
|
|
18.2
|
%
|
|
36,078
|
|
|
19.7
|
%
|
||
Amortization of intangible assets
|
1,636
|
|
|
0.9
|
%
|
|
2,095
|
|
|
1.2
|
%
|
||
Total operating expenses
|
$
|
55,046
|
|
|
28.9
|
%
|
|
$
|
56,703
|
|
|
31.0
|
%
|
|
Three Months Ended
|
||||||
|
December 31,
2011 |
|
January 1,
2011 |
||||
|
(in thousands)
|
||||||
Net cash provided by operating activities
|
$
|
16,135
|
|
|
$
|
29,969
|
|
Sales of shares under employee stock plans
|
4,568
|
|
|
17,331
|
|
||
Repurchase of common stock
|
(20,665
|
)
|
|
—
|
|
||
Capital expenditures
|
(8,139
|
)
|
|
(5,129
|
)
|
|
December 31, 2011
|
|
October 1, 2011
|
||||
|
(in thousands)
|
||||||
Cash and cash equivalents
|
$
|
167,662
|
|
|
$
|
167,061
|
|
Short-term investments
|
35,421
|
|
|
53,142
|
|
||
Working capital
|
412,065
|
|
|
418,241
|
|
||
Total debt obligations
|
30
|
|
|
34
|
|
|
Average Contract
Rate
|
|
U.S. Notional
Contract Value
|
|
U.S. Notional
Fair Value
|
|||||
Euro
|
1.3188
|
|
|
$
|
(47,843
|
)
|
|
$
|
(47,344
|
)
|
Japanese Yen
|
77.722
|
|
|
$
|
10,688
|
|
|
$
|
10,711
|
|
Canadian Dollar
|
0.9714
|
|
|
$
|
562
|
|
|
$
|
571
|
|
British Pound
|
1.5571
|
|
|
$
|
6,043
|
|
|
$
|
6,056
|
|
Korean Won
|
1,157.325
|
|
|
$
|
22,798
|
|
|
$
|
22,820
|
|
Chinese Renminbi
|
6.3770
|
|
|
$
|
7,443
|
|
|
$
|
7,505
|
|
(i)
|
pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;
|
(ii)
|
provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and
|
(iii)
|
provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on the financial statements.
|
•
|
general economic uncertainties in the macroeconomic and local economies facing us, our customers and the markets we serve;
|
•
|
access to applicable credit markets by us, our customers and their end customers;
|
•
|
fluctuations in demand for our products or downturns in the industries that we serve;
|
•
|
the ability of our suppliers, both internal and external, to produce and deliver components and parts, including sole or
|
•
|
the timing of conversion of booking to revenue;
|
•
|
timing or cancellation of customer orders and shipment scheduling;
|
•
|
fluctuations in our product mix;
|
•
|
the ability of our customers' suppliers to provide sufficient material to support our customers' products;
|
•
|
currency fluctuations and stability, in particular the Euro;
|
•
|
commodity pricing;
|
•
|
introductions of new products and product enhancements by our competitors, entry of new competitors into our markets, pricing pressures and other competitive factors;
|
•
|
our ability to develop, introduce, manufacture and ship new and enhanced products in a timely manner without defects;
|
•
|
our ability to manage our capacity and that of our suppliers;
|
•
|
our increased reliance on domestic and foreign contract manufacturing;
|
•
|
the rate of market acceptance of our new products;
|
•
|
the ability of our customers to pay for our products;
|
•
|
expenses associated with acquisition-related activities;
|
•
|
seasonal sales trends;
|
•
|
delays or reductions in customer purchases of our products in anticipation of the introduction of new and enhanced products by us or our competitors;
|
•
|
our ability to control expenses;
|
•
|
the level of capital spending of our customers;
|
•
|
potential excess and/or obsolescence of our inventory;
|
•
|
costs and timing of adhering to current and developing governmental regulations and reviews relating to our products and business;
|
•
|
costs related to acquisitions of technology or businesses;
|
•
|
impairment of goodwill, intangible assets and other long term assets;
|
•
|
our ability to meet our expectations and forecasts and those of public market analysts and investors;
|
•
|
costs and expenses from litigation;
|
•
|
the availability of research funding by governments with regard to our customers in the scientific business, such as universities;
|
•
|
continued government spending on defense-related projects where we are a subcontractor;
|
•
|
government support of the alternative energy industries, such as solar;
|
•
|
maintenance of supply relating to products sold to the government on terms which we would prefer not to accept;
|
•
|
changes in policy, interpretations, or challenges to the allowability of costs incurred under government cost accounting standards;
|
•
|
damage to our reputation as a result of coverage in social media, Internet blogs or other media outlets;
|
•
|
managing our and other parties' compliance with contracts in multiple languages and jurisdictions;
|
•
|
managing our internal and third party sales representatives and distributors, including compliance with all applicable laws;
|
•
|
costs associated with designing around or payment of licensing fees associated with issued patents in our fields of business;
|
•
|
the future impact of legislation, rulemaking, and changes in accounting, tax, defense procurement, or export policies; and
|
•
|
distraction of management related to acquisition or divestment activities.
|
•
|
longer accounts receivable collection periods;
|
•
|
the impact of recessions and other economic conditions in economies outside the United States;
|
•
|
unexpected changes in regulatory requirements;
|
•
|
certification requirements;
|
•
|
environmental regulations;
|
•
|
reduced protection for intellectual property rights in some countries;
|
•
|
potentially adverse tax consequences;
|
•
|
political and economic instability;
|
•
|
import/export regulations, tariffs and trade barriers;
|
•
|
compliance with applicable United States and foreign anti-corruption laws;
|
•
|
cultural and management differences;
|
•
|
preference for locally produced products; and
|
•
|
shipping and other logistics complications.
|
•
|
stop manufacturing, selling or using our products that use the infringed intellectual property;
|
•
|
obtain from the owner of the infringed intellectual property right a license to sell or use the relevant technology, although such license may not be available on reasonable terms, or at all; or
|
•
|
redesign the products that use the technology.
|
•
|
loss of customers;
|
•
|
increased costs of product returns and warranty expenses;
|
•
|
damage to our brand reputation;
|
•
|
failure to attract new customers or achieve market acceptance;
|
•
|
diversion of development and engineering resources; and
|
•
|
legal actions by our customers and/or their end users.
|
•
|
issue stock that would dilute our current stockholders' percentage ownership;
|
•
|
pay cash that would decrease our working capital;
|
•
|
incur debt;
|
•
|
assume liabilities; or
|
•
|
incur expenses related to impairment of goodwill and amortization.
|
•
|
problems combining the acquired operations, systems, technologies or products;
|
•
|
an inability to realize expected operating efficiencies or product integration benefits;
|
•
|
difficulties in coordinating and integrating geographically separated personnel, organizations, systems and facilities;
|
•
|
difficulties integrating business cultures;
|
•
|
unanticipated costs or liabilities, including the costs associated with improving the internal controls of the acquired company;
|
•
|
diversion of management's attention from our core businesses;
|
•
|
adverse effects on existing business relationships with suppliers and customers;
|
•
|
potential loss of key employees, particularly those of the purchased organizations;
|
•
|
incurring unforeseen obligations or liabilities in connection with acquisitions; and
|
•
|
the failure to complete acquisitions even after signing definitive agreements which, among other things, would result in the expensing of potentially significant professional fees and other charges in the period in which the acquisition or negotiations are terminated.
|
•
|
maintaining and enhancing our relationships with our customers;
|
•
|
the education of potential end-user customers about the benefits of lasers and laser systems; and
|
•
|
our ability to accurately predict and develop our products to meet industry standards.
|
•
|
the ability of our Board of Directors to alter our bylaws without stockholder approval;
|
•
|
limiting the ability of stockholders to call special meetings; and
|
•
|
establishing advance notice requirements for nominations for election to our Board of Directors or for proposing matters that can be acted on by stockholders at stockholder meetings.
|
Period
|
Total
Number of
Shares
Purchased
|
|
Average Price Paid per Share
|
|
Total Number of
Shares Purchased as
Part of Publicly
Announced Plans or
Programs
|
|
Maximum Dollar
Value that May
Yet Be Purchased
Under the Plans or
Programs (1)
|
|
|||||
October 2, 2011 - October 29, 2011
|
334,200
|
|
|
$
|
45.28
|
|
|
334,200
|
|
|
|
$9,852,000
|
|
October 30, 2011 - November 26, 2011
|
26,100
|
|
|
$
|
47.96
|
|
|
26,100
|
|
|
$8,600,000
|
|
|
November 27, 2011 - December 31, 2011
|
90,200
|
|
|
$47.30
|
|
90,200
|
|
|
$4,333,000
|
|
|||
Total
|
450,500
|
|
|
$45.84
|
|
450,500
|
|
|
|
$4,333,000
|
|
Exhibit No.
|
|
Description
|
|
|
|
10.1‡
|
|
Coherent, Inc. 2005 Deferred Compensation Plan, as amended.
|
|
|
|
31.1
|
|
Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a)/15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
31.2
|
|
Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a)/15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
32.1
|
|
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
32.2
|
|
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
101.INS*
|
|
XBRL Instance Document
|
|
|
|
101.SCH*
|
|
XBRL Taxonomy Extension Schema
|
|
|
|
101.CAL*
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
|
|
101.DEF*
|
|
XBRL Taxonomy Extension Definition Linkbase
|
|
|
|
101.LAB*
|
|
XBRL Taxonomy Extension Label Linkbase
|
|
|
|
101.PRE*
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
*
|
In accordance with Rule 406T of Regulation S-T, the information in these exhibits is furnished and deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Exchange Act of 1934, and otherwise is not subject to liability under these sections.
|
|
|
Coherent, Inc.
|
|
|
|
(Registrant)
|
|
|
|
|
|
Date:
|
February 8, 2012
|
/s/:
|
JOHN R. AMBROSEO
|
|
|
|
John R. Ambroseo
|
|
|
|
President and Chief Executive Officer
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
Date:
|
February 8, 2012
|
/s/:
|
HELENE SIMONET
|
|
|
|
Helene Simonet
|
|
|
|
Executive Vice President and Chief Financial Officer
|
|
|
|
(Principal Financial and Accounting Officer)
|
Exhibit No.
|
|
Description
|
|
|
|
10.1‡
|
|
Coherent, Inc. 2005 Deferred Compensation Plan, as amended.
|
|
|
|
31.1
|
|
Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a)/15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
31.2
|
|
Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a)/15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
32.1
|
|
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
32.2
|
|
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
101.INS*
|
|
XBRL Instance Document
|
|
|
|
101.SCH*
|
|
XBRL Taxonomy Extension Schema
|
|
|
|
101.CAL*
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
|
|
101.DEF*
|
|
XBRL Taxonomy Extension Definition Linkbase
|
|
|
|
101.LAB*
|
|
XBRL Taxonomy Extension Label Linkbase
|
|
|
|
101.PRE*
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
*
|
In accordance with Rule 406T of Regulation S-T, the information in these exhibits is furnished and deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Exchange Act of 1934, and otherwise is not subject to liability under these sections.
|
TABLE OF CONTENTS
|
|||
|
|
Page
|
|
|
|
|
|
ARTICLE I Definitions
|
1
|
|
|
|
1.1 Definitions
|
1
|
|
ARTICLE II Participation
|
4
|
|
|
|
2.1 Date of Participation
|
4
|
|
|
2.2 Resumption of Participation Following Return to Service
|
4
|
|
|
2.3 Change in Employment Status
|
5
|
|
ARTICLE III Contributions
|
5
|
|
|
|
3.1 Deferral Contributions
|
5
|
|
|
3.2 Accounts
|
6
|
|
|
3.3 Company Discretionary Contributions
|
7
|
|
|
3.4 Cancellation of Elections Due to 401(k) Hardship Withdrawal or Unforeseeable Emergency Distribution
|
7
|
|
ARTICLE IV Participants' Accounts
|
7
|
|
|
|
4.1 Individual Accounts
|
7
|
|
|
4.2 Accounting for Distributions
|
8
|
|
|
4.3 Separate Accounts
|
8
|
|
ARTICLE V Investment of Contributions
|
8
|
|
|
|
5.1 Manner of Investment
|
8
|
|
|
5.2 Investment Decisions
|
8
|
|
ARTICLE VI Distributions
|
8
|
|
|
|
6.1 Certain Distributions to Participants and Beneficiaries
|
8
|
|
|
6.2 Subsequent Election to Delay or Change Form of Payment.
|
9
|
|
|
6.3 Lump-Sum Distribution Timing
|
10
|
|
|
6.4 Installment Amounts
|
10
|
|
|
6.5 Unforeseeable Emergency Distributions
|
10
|
|
|
6.6 Scheduled In-Service Distribution
|
11
|
|
|
6.7 Death
|
11
|
|
|
6.8 Notice to Trustee
|
12
|
|
|
6.9 Time of Distribution
|
12
|
|
|
6.10 Limitation on Distributions to Covered Employees Prior to a Change of Control
|
12
|
|
|
6.11 Domestic Relations Order Distributions
|
12
|
|
|
6.12 Conflicts of Interest and Ethics Rules Distributions
|
12
|
|
|
6.13 FICA and Related Income Tax Distribution
|
13
|
|
TABLE OF CONTENTS
|
|||
|
|
Page
|
|
|
6.14 State, Local and Foreign Tax Distribution
|
13
|
|
|
6.15 Code Section 409A Distribution
|
13
|
|
|
6.16 Tax Withholding
|
13
|
|
|
6.17 Special 2008 Election
|
13
|
|
ARTICLE VII Change of Control
|
13
|
|
|
|
7.1 No New Participants Following Change of Control
|
13
|
|
|
7.2 Discretionary Termination and Accelerated Plan Distributions 30 Days Prior to or Within 12 Months Following a Change in Control
|
13
|
|
ARTICLE VIII Termination Due to Corporate Dissolution or Pursuant to Bankruptcy Court Approval
|
14
|
|
|
|
8.1 Corporate Dissolution
|
14
|
|
|
8.2 Bankruptcy Court Approval
|
14
|
|
ARTICLE IX Amendment and Termination
|
14
|
|
|
|
9.1 Amendment by Employer
|
14
|
|
|
9.2 Retroactive Amendments
|
14
|
|
|
9.3 Plan Deferral Termination
|
14
|
|
|
9.4 Distribution upon Certain Plan Terminations
|
14
|
|
ARTICLE X The Trust
|
15
|
|
|
|
10.1 Establishment of Trust
|
15
|
|
ARTICLE XI Miscellaneous
|
15
|
|
|
|
11.1 Limitation of Rights
|
15
|
|
|
11.2 Nontransferability; Domestic Relations Orders
|
15
|
|
|
11.3 Facility of Payment
|
15
|
|
|
11.4 Information between Employer and Trustee
|
16
|
|
|
11.5 Notices
|
16
|
|
|
11.6 Governing Law
|
16
|
|
|
11.7 No Guarantees Regarding Tax Treatment; Disclaimer
|
16
|
|
ARTICLE XII Plan Administration
|
16
|
|
|
|
12.1 Powers and responsibilities of the Administrator
|
16
|
|
|
12.2 Nondiscriminatory Exercise of Authority
|
17
|
|
|
12.3 Claims and Review Procedures
|
17
|
|
|
12.4 Exhaustion of Claims Procedure and Right to Bring Legal Claim
|
20
|
|
|
12.5 Plan's Administrative Costs
|
20
|
|
|
|
|
3.4
|
Cancellation of Elections Due to 401(k) Hardship Withdrawal or Unforeseeable Emergency Distribution
.
|
|
COHERENT, INC.
|
|
|
By:
|
/s/ HELENE SIMONET
|
|
Helene Simonet
|
|
|
Date:
|
February 2, 2012
|
Date:
|
February 8, 2012
|
|
|
|
|
|
|
|
/s/: JOHN R. AMBROSEO
|
|
|
John R. Ambroseo
|
|
|
President and Chief Executive Officer
|
|
Date:
|
February 8, 2012
|
|
|
|
|
|
|
|
/s/: HELENE SIMONET
|
|
|
Helene Simonet
|
|
|
Executive Vice President and Chief Financial Officer
|
|
Date:
|
February 8, 2012
|
|
|
|
|
|
|
|
/s/: JOHN R. AMBROSEO
|
|
|
John R. Ambroseo
|
|
|
President and Chief Executive Officer
|
|
Date:
|
February 8, 2012
|
|
|
|
|
|
|
|
/s/: HELENE SIMONET
|
|
|
Helene Simonet
|
|
|
Executive Vice President and Chief Financial Officer
|
|